Delivery Order SPE2DB22D1202-SPE2DB24FVEV2

Award Date 6/25/24
Potential Completion Date 7/17/24
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on April 2, 2025 with a completion date of April 3, 2025. The contract has a ceiling value of $3,158.53 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,574.56 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024 with a completion date of November 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $33,105.03 and an ultimate completion date of December 18, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 17, 2024. This appears to be a delivery order contract, with a firm fixed price pricing type. The contract...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,990.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,760.60 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 28, 2025. The contract is not designated with a...
This federal contract award is for the pharmaceutical product COSENTYX UNOREADY 300 MG PEN 2ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,523.99 and is a Firm Fixed Price Delivery Order that runs through March 3, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Cosentyx Unoready 300 mg pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,837.91 firm fixed price contract was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $10,004.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, and has an ultimate completion date of March 24, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award is a delivery order worth $4,588.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,588.15 and an ultimate completion date of November 22, 2023. The contract is a firm fixed-price delivery order and does not have a...
This federal contract award, valued at $9,415.44, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, with a completion date of February 18, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVEV2
    Delivery Order

This federal contract award is for the delivery of 4,565,107,314 units of the COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical product to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $7,609.75 and an ultimate completion date of July 17, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract award is not designated as a set-aside.

Generated 9/24/24, 9:36 AM